Titlebook: Recent Advances in Retinoblastoma Treatment; Jasmine H. Francis,David H. Abramson Book 2015 Springer International Publishing Switzerland

微塵

他一致

無(wú)動(dòng)于衷

Treatment of Extraocular Retinoblastoma,y intraocular in nature with highly favorable survival rates. This is due in part to the availability of multi-modality treatment options including enucleation, chemotherapy, local therapies, and external beam radiation therapy. In contrast, retinoblastoma most commonly presents as extraocular disea

Antigen

Second Tumors in Retinoblastoma Survivors, cancers have emerged as a major cause of morbidity and mortality in retinoblastoma survivors. Several large cohort studies of long-term survivors have consistently reported that hereditary survivors have a greater risk of second cancers compared to non-hereditary survivors, with elevated risks pers

粗鄙的人

Long-Term Follow-Up of Retinoblastoma Survivors,tion has been given to the delineation, early identification, and treatment of survivors’ potential late effects of therapy, which may develop many years after initial treatment. While adverse oculo-visual outcomes and an increased risk of subsequent primary malignancies (in those with the genetic f

浮雕

蒸發(fā)

Semblance

萬(wàn)靈丹

詞匯